MaryEapenMD
Pediatric Hematology & Oncology • Milwaukee, WIAssociate Professor, Medicine, Medical College of Wisconsin
Are you Dr. Eapen?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 32 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
9000 W Wisconsin Ave
Division Of Pediatric Hematology/Oncology
Milwaukee, WI 53226Phone+1 414-456-4170Fax+1 414-456-6543
Summary
- Dr. Mary Eapen, MD is a pediatric hematologist/oncologist in Milwaukee, Wisconsin. She is currently licensed to practice medicine in Wisconsin and Minnesota. She is affiliated with Froedtert and the Medical College of Wisconsin Froedtert Hospital and Children's Wisconsin.
Education & Training
University of MinnesotaFellowship, Pediatric Hematology/Oncology, 1997 - 2000- University of MinnesotaResidency, Pediatrics, 1995 - 1997
Ahmadu Bello UniversityClass of 1986
Certifications & Licensure
WI State Medical License 2000 - 2025
MN State Medical License 1998 - 2020- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Bone Marrow Transplantation vs Standard of Care in Patients With Severe Sickle Cell Disease (BMT CTN 1503) Start of enrollment: 2016 Nov 01
Publications & Presentations
PubMed
- Platelet-Targeted Gene Therapy for Hemophilia A with Inhibitor History.Mary Eapen, Lynn M Malec, Myriam A Armant, Bryon D Johnson, Qizhen Shi
The New England Journal of Medicine. 2025-01-23 - Incremental eligibility criteria for the BMT CTN 1507 haploidentical trial for children with sickle cell disease.Tami D John, Mark C Walters, Hemalatha G Rangarajan, Mahvish Q Rahim, Christopher McKinney
Blood Advances. 2024-12-10 - Hematopoietic Cell Transplant compared with Standard Care in Adolescents and Young Adults with Sickle Cell Disease.Mark C Walters, Mary Eapen, Yiwen Liu, Fuad El Rassi, Edmund K Waller
Blood Advances. 2024-10-29
Press Mentions
Researchers Develop a Validated Pediatric Disease Risk Index for AML and ALLFebruary 1st, 2021- Navigating Treatment Options and Communication in Relapsed Pediatric AMLJune 17th, 2024
